Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

Please provide your email address to receive an email when new articles are posted on . “Glaucoma requires the continuous long-term engagement of the patient with the recommendation proposed by the ...

Amring is offering timolol maleate ophthalmic solution, 0.5%, 60 pack of 0.3 ml unit dose vials, which is a generic of Timoptic in Ocudose. Preservative-free timolol maleate ophthalmic solution is ...

A new meta-analysis finds rigorous evidence lacking; however, existing data suggest preservative-free formulations of beta-blockers may work just as well as preserved beta-blockers in reducing ...

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate ...

Please provide your email address to receive an email when new articles are posted on . Imprimis Pharmaceuticals is now dispensing preservative-free dorzolamide and a preservative-free ...

COSOPT PF (dorzolamide HCl, timolol maleate) 2%, 0.5% ophthalmic solution by Merck Cosopt PF (dorzolamide HCl 2%, timolol maleate 0.5% ophthalmic solution), the preservative-free formulation of Cosopt ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it signed an agreement for Santen Pharmaceutical Co., Ltd. (Santen) ...

WHITEHOUSE STATION, N.J., May 2, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ...

Merck Signs Sale Agreement with Santen for Merck's Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD ...